Price Alert

Opus Genetics Inc. (IRD)

NASDAQ: IRD · Real-Time Price · USD

1.19

0.01 (0.85%)

At close: Aug 15, 2025, 3:59 PM

1.20

0.84%

After-hours: Aug 15, 2025, 04:10 PM EDT

0.85% (1D)

Bid	1.17
Market Cap	71M
Revenue (ttm)	13.65M
Net Income (ttm)	-58.62M
EPS (ttm)	-1.88
PE Ratio (ttm)	-0.63
Forward PE	-1.6
Analyst	Buy

Ask	1.23
Volume	307,770
Avg. Volume (20D)	1,076,593
Open	1.20
Previous Close	1.18
Day's Range	1.16 - 1.24
52-Week Range	0.65 - 1.75
Beta	0.29

About IRD

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol IRD

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for IRD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Opus Genetics Inc. is scheduled to release its earnings on Nov 11, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 months ago

+9.6%

Opus Genetics shares are trading higher after the ... Unlock content with Pro Subscription

7 months ago

+18.93%

Opus Genetics shares are trading higher after the company announced it secured an FDA agreement under special protocol assessment for its Phase 3 trial of Oral APX3330 in diabetic retinopathy.

News

2 days ago · zacks.com

Opus Genetics, Inc. (IRD) Reports Q2 Loss, Lags Revenue Estimates

Opus Genetics, Inc. (IRD) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.3 per share a year ago.

3 months ago · zacks.com

Opus Genetics, Inc. (IRD) Reports Q1 Loss, Tops Revenue Estimates

Opus Genetics, Inc. (IRD) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.29 per share a year ago.